Article thumbnail

A novel strategy to achieve effective drug delivery: exploit cells as carrier combined with nanoparticles

By Liang Pang, Chun Zhang, Jing Qin, Limei Han, Ruixiang Li, Chao Hong, Huining He and Jianxin Wang

Abstract

Cell-mediated drug delivery systems employ specific cells as drug vehicles to deliver drugs to targeted sites. Therapeutics or imaging agents are loaded into these cells and then released in diseased sites. These specific cells mainly include red blood cells, leukocytes, stem cells and so on. The cell acts as a Trojan horse to transfer the drug from circulating blood to the diseased tissue. In such a system, these cells keep their original properties, which allow them to mimic the migration behavior of specific cells to carry drug to the targeted site after in vivo administration. This strategy elegantly combines the advantages of both carriers, i.e. the adjustability of nanoparticles (NPs) and the natural functions of active cells, which therefore provides a new perspective to challenge current obstacles in drug delivery. This review will describe a fundamental understanding of these cell-based drug delivery systems, and discuss the great potential of combinational application of cell carrier and NPs

Topics: Red blood cell, leukocyte, stem cell, carrier, nanoparticle, Therapeutics. Pharmacology, RM1-950
Publisher: Taylor & Francis Group
Year: 2017
DOI identifier: 10.1080/10717544.2016.1230903
OAI identifier: oai:doaj.org/article:c9e8d181c0114ba4ac19bb5cfa2548ad
Journal:
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://dx.doi.org/10.1080/1071... (external link)
  • https://doaj.org/toc/1521-0464 (external link)
  • https://doaj.org/article/c9e8d... (external link)
  • https://doaj.org/toc/1071-7544 (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.